|
NCI-funded Research at the 2024 San Antonio Breast Cancer Symposium
Tuesday, December 10 – Friday, December 13
This year’s Symposium will include several sessions from researchers presenting DCP-funded work from NCORP and the Cancer Grand Challenges Program.
Read more.
|
NCI Cancer Integrative Medicine Grantee Conference
Tuesday, December 10-Wednesday, December 11 Registration required (open to the public)
This free virtual conference will provide opportunities for learning about grantsmanship, tools, and resources from NCI and the National Institutes of Health (NIH), and for NCI program staff to hear about grantee needs and challenges. The conference will also highlight NCI/NIH funded cancer-related complementary and integrative medicine research and identify gaps or needs for future research, and technology to advance precision integrative oncology.
Learn more.
|
|
|
Meet the 2025 Cohort of the DCP Early Career Scientists
DCP is pleased to announce the 2025 cohort of the DCP Early Career Scientist Spotlight Research Seminar Series. The nine selected investigators are advancing research within prevention, detection, and symptom science. They will be featured in a series of public seminars intended to highlight their work in these important research areas.
Read more.
|
A Deep Dive into Awareness and Perceptions of Potential Benefits and Harms of Multi-Cancer Detection Tests
This blog delves into recent NCI-facilitated focus groups with practicing primary care physicians and laypersons to learn about their awareness and knowledge of multi-cancer detection (MCD) tests and their thoughts on the benefits, harms, uncertainties, and acceptability of using this emerging technology. Despite limited evidence on their benefit, some MCD tests are currently available to the public as cancer screening tools and many more are in development.
Read the Cancer Prevention Science Blog.
|
|
|
Notice of Funding Opportunities (NOFOs) |
|
NCI Clinical and Translational Exploratory/Developmental Studies
Through this Notice of Funding Opportunity (NOFO), NCI intends to support research directly related to advancements in cancer treatment, diagnosis, prevention, comparative oncology, symptom management, or reduction of cancer disparities.
PAR-25-139 (R21 Clinical Trial Optional)
Expires: July 2, 2025
Biology of Bladder Cancer
Through these NOFOs, NCI encourages applications that investigate the biology and underlying mechanisms of bladder cancer to help better the understanding of bladder cancer biology and contribute to the future development of new interventions.
PAR-25-128 (R21 Clinical Trial Optional)
PAR-25-129 (R01 Clinical Trial Optional)
Expires: September 8, 2025
Digital Health Technology Derived Biomarkers and Outcome Assessments for Remote Monitoring and Endpoint Development
|
The purpose of this NOFO is to support rigorous development and validation of Digital Health Technology derived biomarkers or clinical outcome assessments for remote monitoring to fill a defined unmet clinical endpoint for interventional clinical trials.
PAR-25-170 (UG3/UH3 Clinical Trial Optional)
Expires: June 23, 2026
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research
|
Through this NOFO, NCI encourages applications that support the biochemical and genetic analyses of cancer risk, and the discovery and validation of early detection biomarkers. Selected applicants will use the unique biorepository resources of the NCI-sponsored Prostate, Lung, Colorectal, and Ovarian Cancer (PLCO) Screening Trial.
PAR-25-248 (U01 Clinical Trial Not Allowed)
Expires: October 9, 2027
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies
|
The purpose of this NOFO is to promote research studies designed to address adverse sequelae of cancer therapies that persist and become chronic co-morbidities or develop as delayed posttreatment effects.
PAR-25-145 (R01 Clinical Trial Optional)
Expires: January 8, 2028
|
|
|
Changes Coming to NIH Applications and Peer Review in 2025
Multiple changes are coming in 2025 that will affect the submission and review of NIH grant applications.
Although each of these initiatives has specific goals, they are all meant to simplify, clarify, and/or promote greater fairness towards a level playing field for applicants throughout the application and review processes.
Learn more about these changes coming in 2025.
Updated Guidance for Investigators Planning to Submit a P01
The NCI Division of Cancer Prevention has updated guidance to support submission of Program Project Grants (P01). These grants support investigator-initiated multi-project research programs with a major objective or theme relevant to cancer research.
Read the guidance.
In case you missed it:
Read more DCP Updates.
Follow DCP's LinkedIn page.
See all Meetings and Events on the DCP Website.
Do you forward DCP Updates to others?
Encourage them to subscribe.
|
|
|
|
